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ESCHARECTOMY has been shown to improve the survi-
val rates and the outcomes in burns. This observa-
tional study was conducted to assess the role
of escharectomy on the inflammatory mediators in
major burns. Seventeen ASA physical status II
or status III adult surviving major burn patients
were recruited. When the escharectomy was sched-
uled, a series of blood samples was obtained at  /3
and  /1 days preoperation, and  /1 and  /3 post-
operation. The changing levels of endotoxin, cyto-
kines, and adhesion molecules were measured with a
quantitative sandwich immunoassay. Extensive es-
charectomy did not appear to have any significant
impact on the levels of tumor necrosis factor alpha,
interleukin-10, soluble intracellular adhesion mole-
cule-1 and soluble vascular adhesion molecule-1.
Meanwhile, endotoxin and E-selectin were signifi-
cantly decreased after escharectomy. Escharectomy
appeared to have a limited immunomodulatory
effect on the inflammatory mediators in systemic
inflammatory responses induced by major burns.
This is probably related to the timing and extent of
surgery, and the complex nature of burn-related
inflammation.
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Introduction
The patho-physiological events following the im-
mense tissue damage of major burn injury include
the surface effects of the heat on superficial tissue,
but also should be viewed as an acute systemic
illness,
1,2 initiated by a number of processes such as
the development of ischemia-reperfusion injury re-
lated to burn shock and resuscitation as well as the
presence of endotoxemia.
3 Major burns produce both
local and systemic disturbances due to the release of
inflammatory mediators, depending upon the type
and extent of burn and the time elapsed since the
injury.
4
The acute inflammatory response results from an
integration of a complex cascade of events, including
vasodilation, increased vascular permeability, and
exudation of fluid and plasma protein. The rapid
overproduction of inflammatory active substances,
leukocyte activation, activation of endothelial cells,
and expression of adhesion molecules and induction
of nitric oxide synthase all lead to systemic inflam-
matory response syndrome (SIRS), resulting in pro-
gressive multi-organ failure and death.
5 7
Many experimental and clinical studies have de-
monstrated a pronounced immunosuppression fol-
lowing major burn injury.
8 Since burn eschar is
thought to be the source of denatured proteins,
mediators, and toxins, which cause immunosuppres-
sion and infection, prompt excision of burn eschar
could be an effective way to avoid absorption of
immunosuppressive substances.
9 Removing the dead
devitalized tissue and grafting would not only
remove the source of infection, but also decrease
the release of inflammatory mediators, and improve
survival, prevent postburn immunosuppression and
maintain skin barrier function.
10 Experimentally,
although some specific parameters of immunity
may be improved by early excision and wound
closure,
11 little defined physiologic benefit has been
proved.
A variety of inflammatory mediators such as
endotoxin, complement fragments, cytokines, adhe-
sion molecules and lipid mediators are generated
shortly after the burn injury at the site of the initial
lesion and serve to recruit inflammatory cells at the
later stages. In the present study, we measured the
dynamic changes of the levels of endotoxin, proin-
flammatory and anti-inflammatory cytokines, and
soluble adhesion molecules, and compared their
relations before and after extensive escharectomy.
Attempts were made to better understand the im-
munological role of extensive early escharectomy in
preventing SIRS.
Research Communication
ISSN 0962-9351 print/ISSN 1466-1861 online – 2004 Taylor & Francis Ltd
DOI: 10.1080/09629350400003191
241Materials and methods
The protocol was reviewed and approved by the
institutional ethics committee for human study, and
written informed consent was obtained before the
study from each patient or legal guardian if mentally
incompetent.
When a major burn patient with possible candi-
dacy for the study arrived in the emergency depart-
ment, the anesthesia department was notified for the
potential study subject identification. As the patients
were scheduled for the escharectomy, the primary
investigator was informed at least 3 days before.
At this time, patients were selected based upon
their clinical status, and those with inhalational injury,
SIRS, sepsis, septic shock, adult respiratory distress
syndrome and multiple organ dysfunction syndromes
were included. The guidelines were based on the
criteria of the College of Chest Physicians/Society of
Critical Care Medicine.
12,13
Patients who suffered from any type of immune
deficiency syndrome, had taken any immune ther-
apy, steroids or anticancer drug, any hormonal
medications or who had immune system disease
were excluded from the study. Since it has been well
known that non-survivors have an exponential in-
crease in the inflammatory mediators, concerns were
raised that those results might falsely elevate the
levels. Therefore, samples from those patients were
excluded in the final analysis.
On recruitment, an arterial line for multiple sam-
pling was placed in either the upper or lower
extremity, in the intensive care unit, and locked
with heparin. Serial collections were performed four
times between 8:00 and 9:00 a.m. at 72 and 24 h
before and 24 and 72 h after the surgery. Three
milliliters of blood specimens were collected in
endotoxin-free ethylenediamine tetraacetic acid-con-
taining blood specimen tubes (BD Vacutainer
TM;
BD Vacutainer Systems, Plymouth, UK). These were
immediately centrifuged at 3000 rpm for 60 sec within
30 min of blood sampling, and platelet-rich plasma
was obtained and stored in aliquots at   /708C until
the later combined assay. These samples were kept in
the refrigerator until each individual patient’s even-
tual outcome was determined. All the samples were
analyzed at one time, approximately 3 months after
the collections were completed.
Anesthesia was induced by intravenous sodium
thiopental, vecuronium and fentanyl, and was main-
tained by continuous infusion of fentanyl, nitrous
oxide and oxygen, and sevoflurane. Intermittent
boluses of vecuronium provided muscle relaxation.
Endotoxin levels were measured by the chromo-
genic limulus amebocyte lysate (LAL) test (QCL
1000†; Biowhittaker, East Rutherford, NJ, USA),
which is a quantitative test for Gram-negative bacter-
ial endotoxin. A sample is mixed with the LAL
supplied in the test kit and incubated at 378Cf o r1 0
min. A substrate solution is then mixed with the LAL
sample and incubated at 378C for an additional 6 min.
The reaction is stopped with stop reagent. If en-
dotoxin is present in the sample, a yellow color will
develop. The absorbance of the sample can be
determined spectrophotometrically at 405 /410 nm.
Since this absorbance is in direct proportion to the
amount of endotoxin present, the concentration of
endotoxin can be calculated from a standard curve.
Cytokines of tumor necrosis factor alpha (TNF-a)
and interleukin-10 (IL-10) were measured with quan-
titative sandwich enzyme-linked immunosorbent as-
say (ELISA) test kits (Quantikine†; R & D systems,
Inc., Minneapolis, MN, USA) according to instructions
given by the manufacturer and optical densitometry.
These assays did not measure biological activity, but
rather quantitative assessment of immunoreactivity is
provided. The minimum detectable doses of TNF-a
and IL-10 with these kits were 4 and 3.9 pg/ml.
Three adhesion molecules of soluble intracellular
adhesion molecule-1 (sICAM-1), soluble vascular
adhesion molecule-1 (sVCAM-1), and E-selectin
were all measured similarly with the same quantita-
tive sandwich ELISA test kit and optical densitometry.
The minimum detectable doses of sICAM-1, sVCAM-1
and E-selectin were 0.35, 0.6, and 0.5 pg/ml, respec-
tively.
Measured parameters included the demographic
and surgical data such as age, gender, height and
weight, burn type and percent of total body surface
area, as well as American Society of Anesthesiologists
physical status classification.
The SPSS program (version 10.01; SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis
and all values are expressed as mean9 /standard
deviation. Demographic and surgical data were
summarized by descriptive analysis. The level of
changes of endotoxin, cytokines, adhesion molecules
and E-selectin were individually determined with
repeated-measures of analysis of variance (ANOVA)
with Bonferroni’s correction. Each patient served as
their own control, values were compared before and
after the escharectomy. pB /0.05 was considered
statistically significant. Pearson’s correlations were
performed to delineate the relationship between the
various inflammatory mediators.
Results
A total of 25 patients were recruited, and from these
three expired within 1 week after the escharectomy
and another five suffered from major complications
described as follows before or after surgery. Those
samples were exempted from final analysis. The
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body surface area of 25% or more, who survived
more than 3 months after blood sampling, and from
whom blood specimens could be repeatedly ob-
tained. Every other day samples from those patients
were finally analyzed with ELISA.
The patients’ characteristics and surgical data are
summarized in Table 1. Most suffered from extensive
major burns. The removal of dead devitalized tissue
was performed approximately within 1 week.
Figure 1 shows the changes of endotoxin levels
perioperatively. Statistically significant differences
were noted before and after escharectomy.
Figure 2 shows the changes of TNF-a and IL-10. In
both groups, only day   /1 showed a significant
decrease in their levels. These were increased
at   /3 days, following the increasing trend again.
Interestingly, the level would have been thought to
be there anyway even without the scheduled eschar-
ectomy.
Figure 3 shows the changes of adhesion molecules.
sICAM-1 showed a continued increasing trend re-
gardless of escharectomy compared with the base-
line. In contrast, sVCAM-1 decreased even before the
surgery, and remained as such during the rest of
study period regardless of the extensive escharect-
omy. It was even slightly increased after the proce-
dure. E-selectin had a statistically meaningful
decrease after the extensive escharectomy and re-
mained at a lower level compared with the baseline
at   /3 days.
Pearson’s correlation analysis revealed statistically
significant high correlations between endotoxin and
E-selectin, as well as between TNF-a and IL-10.
Discussion
In this study, we have shown that the immune
modulatory effect of escharectomy on the kinetics
of endotoxin, cytokines, and adhesion molecules in
major burns appeared to be limited, in that it did not
change that much over a matter of days. In essence,
our data did not demonstrate that the removal of the
burn has much of a profound effect. Although we
found that values of endotoxin and E-selectin de-
creased significantly after escharectomy, it probably
has no clinically significance. In spite of these
findings, it cannot be precluded that early removal
of the burn does not affect the patient’s ability to
survive or resist infection.
A number of reasons should be considered to
explain the limited, minimal responses to escharect-
omy in our study. The patient’s selection issue should
be considered at first. Only the samples taken from
survivors were used for the final analysis. Perhaps the
Table 1. Patient characteristics, American Society of
Anesthesiologists (ASA) physical status classiﬁcation,
and burn data
Characteristic Value
Age (years) 40.99 /9.3
Sex (male/female) 12/5
Weight (kg) 60.59 /4.8
Height (cm) 160.79 /5.6
ASA class (II/III) 3/14
Total body surface area (%) 42.99 /17.0
Elapsed days since initial injury until
escharectomy
5.39 /1.7
Values presented as mean9 /standard deviation.
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FIG. 1. Bar graph illustrating the changing levels of endotox-
in before and after the extensive escharectomy in major
burns (repeated-measures ANOVA, *pB /0.05 when   /3 days
compared with   /1,   /1 and   /3 days,
$pB /0.05 when   /1 day
compared with   /1 and   /3 days).
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FIG. 2. Bar graphs illustrating the changes of TNF-a and IL-10
before and after extensive escharectomy in major burns
(repeated-measures ANOVA, *pB /0.05 when   /3 days com-
pared with   /1,   /1 and   /3 days,
$pB /0.05 when   /1 day
compared with   /1 and   /3 days).
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burns were too small. The immune responses for
the non-survivors have been shown to be dramatic.
14
We intentionally excluded these patients since their
results could have falsely elevated the results and
may have masked the true effect of escharectomy. It
was not surprising that the changing trend was
somewhat less than impressive.
Second, the timing and extent of surgery might
have been another factor. We considered a few days
before and after the burn excision. This may not be
enough time to see a difference. It frequently takes
more time for inflammatory mediators and the stress
response to resolve. In our burn center, it is
customary to perform escharectomy at approximately
5 days (3 /7 days) after initial thermal injury and the
burn shock stage. Furthermore, removing dead and
devitalized tissue is limited and partial, and carried
out in multiple staged operations. It had been
previously suggested that prompt escharectomy
could reduce the production and release of inflam-
matory cytokines, and lessen the myocardial injury
induced by uncontrolled inflammatory response.
Escharectomy en masse during the shock stage could
weaken the ability of burn sera to induce the
secretion of inflammatory cytokines by macrophages.
It was therefore beneficial for the prevention of the
development of postburn systemic inflammatory
response syndrome.
11 The likelihood is high that
when the removal of dead devitalized tissue is
delayed to after the burn shock stage, the systemic
release of inflammatory mediators from the eschar
has already been initiated and settled in the systemic
circulation. Accordingly, escharectomy performed
5 days after the burn trauma as in our study would
not significantly affect the levels of inflammatory
mediators.
Clinically and immunologically, many factors other
than escharectomy should help burn patients. The
use of antibiotics, daily wound dressing, immediate
fluid resuscitation, adequate nutritional support,
management of pulmonary complications and good
covering of the burn wounds have all contributed to
the recuperation of burn patients and improve
immunologically. Postoperatively, the patients still
have donor sites that need to heal, so in essence the
wound is not closed.
Third, the general properties of cytokines and
other inflammatory mediators are very vulnerable
and relatively non-specific, such that production is
dependent on the status of the factories, especially
macrophages. The potential for a self-perpetuating
process, because of a lack of a negative feedback
loop, can explain the progression of inflammation,
sepsis and organ failure, even in the absence of
continuing injury or infection. The level of circulating
cytokines often does not necessarily correlate with
the degree of clinical illness and tissue activity. This is
because the signal to release the secondary mediators
is initiated by the cytokines, and the continued
presence of the signal is no longer required. In
addition, the action of the cytokines is either at the
cell surface receptor or inside the cell, and circulating
levels often do not reflect the intracellular levels. The
patients also have much more pain postoperatively,
which may also turn on cytokine expression. Measur-
ing the cytokines after total healing may make a
difference. For these reasons, it is not surprising that
circulating levels of many of the cytokines often do
not necessarily reflect the clinical status of critically ill
patients, including those with sepsis and burns.
15
Fourth, a variety of inflammatory mediators in
trauma, sepsis and burns interact in a complex
manner to produce the disease state. Multiple altera-
tions in inflammatory and immunologic function
have been demonstrated in clinical and experimental
situations after trauma and hemorrhage; in particular,
the activation of various humoral (e.g. complement,
coagulation) and cellular systems (neutrophils,
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FIG. 3. Bar graphs illustrating the changes of sICAM-1,
sVCAM-1, and E-selectin before and after extensive eschar-
ectomy in major burns (repeated-measures ANOVA, *pB /
0.05 when   /3 days compared with   /1,   /1 and   /3 days,
$pB /0.05 when   /1 day compared with   /1 and   /3 days).
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16 As a consequence
of this activation process, there is synthesis, expres-
sion and release of numerous mediators (toxic
oxygen species, proteolytic enzymes, adhesion mo-
lecules, cytokines), which may produce a generalized
inflammation and tissue damage in the body. Media-
tors are responsible for ongoing interactions of
different cell types and for amplification effects
through their networks and feedback cycles, finally
leading to sustained inflammation and multiple organ
damage in the body. In the setting of trauma and
shock, many activators including bacterial as well as
non-bacterial factors may be present that induce local
and systemic inflammatory responses. Although the
potential role of bacteria and endotoxin translocation
and its clinical relevance remains controversial, many
lines of evidence support the concept that the gut
may be the reservoir for systemic sepsis and sub-
sequent multiple-organ failure in a number of patho-
physiologic states.
17 Many of the problems that burn
doctors deal with come with a secondary infection,
not with the initial insult. If we measured the levels
after sepsis then we might find a more pronounced
difference. Most people are not willing to wait until
patients become sick before they remove the burn.
We all remove it within 1 week, so our patients do
pretty well.
Endotoxin
In burns, endotoxin values were high in the poor
outcome group, serving as the trigger for evolution of
burn-related pathology.
18 Escharectomy during burn
shock was shown to effectively eliminate the effects
of the endotoxemia, thereby preventing the accen-
tuated response to endotoxin that is seen when the
burn wound is left intact, even if it is uninfected.
19
Cytokines
There is a growing interest in determining the role of
TNF-a in burns since an intense immuno-inflamma-
tory reaction is expected to take place in septic
shock, severe sepsis and trauma, including major
burns patients. Many suggest that the beneficial
effects of early extensive burn wound excision and
grafting are likely to be related to the normalization
of increased macrophage TNF-a production, the
amelioration of hypermetabolism with sepsis, as
well as the maintenance of skin barrier function.
9,20,21
We were able to show a temporary TNF-a decrease
to escharectomy, which returned to its increasing
trend again within 72 h at a much higher level than
the baseline. This is probably due to the relatively
non-specific nature of cytokine response to stress.
Unless the devitalized dead tissue is to be removed in
en masse at the early stage of injury, its effect in
TNF-a would probably be minimal.
11 In addition,
clinical deterioration after burn wound dressing or
debridement may be related to predominantly the
systemic release of IL-6, instead of TNF-a.
22
IL-10 exerts a number of anti-inflammatory effects,
including regulation and inhibition of the synthesis of
the inflammatory cytokines and immune responses.
The production of IL-10 seems to be predominantly
stimulated by TNF-a. Hence, they will be likely to
have similar kinetic profiles with TNF-a. Increased
levels of IL-10 have been detected during cardiac
surgery after an increase in the proinflammatory
cytokines, such as TNF-a, and may represent an
endogenous response to limit the inflammatory
response.
23
Adhesion molecules
The importance of early escharectomy during the
burn shock period has been previously emphasized
by the prevention of expression of adhesion mole-
cules including sICAM-1 and E-selectin mRNA and
SIRS.
11 Our results showed that sICAM-1 increased
regardless of the performance of escharectomy. This
can be attributed to the time and extent of surgery, in
that ours was a partial, delayed procedure although it
was extensive.
After a wound revision in severe burns, the
patients may show signs of sepsis, a transient
endotoxemia, and increased expression of the b2
integrin CD11b, as well as elevated plasma levels of
soluble E-selectin, indicating its close association to
systemic inflammation.
24 On the contrary to sICAM-1,
however, E-selectin is a late responder of the
inflammation, which might explain the better re-
sponse to escharectomy performed later stage in our
patients.
25
In conclusion, massive tissue trauma causes im-
mediate activation of endotoxin, selected chemo-
kines and adhesion molecules within minutes of the
injury, which will then persist depending on the type
and severity of the injury for a substantial length of
time. The timing and extent of removal of dead
devitalized tissue is the most influencing factor in
modulating immune mediators. Therefore, the im-
portance of early en masse burn wound excision
during the burn shock stage should be clinically
emphasized in major burn patients to maximize its
benefits, such as decreased susceptibility to compli-
cations or improvement of outcome.
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